Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-18 · accession 0001946439-25-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 2025-12-18 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $82.40 | -1,622 | 58.6K | -3% | -$133.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-18 | S | D | 1,622 | $82.40 | 58,564 | D | — | — |